Infinity Capital Management Co., Ltd. is one of the top 500 Chinese enterprises and the equity investment platform of Huafa Group, a leading state-owned enterprise in Zhuhai. It is an internationally renowned investment management institution with state-owned enterprises and Israeli characteristic resources. As the earliest Sino-foreign cooperative venture capital fund in China, Infinity won the first business license of the non-legal person Sino-foreign cooperative venture capital fund issued by the Chinese government. The founder, Mr. Amir Gal-Or, won the Chinese Government Friendship Award issued by the State Council Office, which is also the highest honor award given by the Chinese government to foreign experts working in China. Infinity Capital has offices in 11 cities across China, covering the five major business areas, Medical Health, East China, South China, Southwest, Hong Kong as well as overseas.
At present, the investment fund of Infinity in China has more than 10 billion RMB invested in new energy, integrated circuits, health and life sciences, advanced manufacturing, new materials and TMT areas. In the last two years, Infinity Capital has had Eleven successful listings: Vincent Medical (01612.HK), AsymChem (002821.SZ), Huati Technology (603679.SH), Liancheng Precision (002921.SZ),Lihu Booster (300694.SZ), BlueSword (688557.SH), Xin Feng Guang (688663.SH), Triductor Technology (688259.SH), SmartGiant (688115.SH), Hinova (688302.SH)、Laekna (2105.HK). Golden Point Gardens, Hongtu Separator, IOPtima has been acquired by Meishang Ecology (300495.SZ). Jinguan Electrical (300510.SZ), Kanghong Pharmaceutical (002773.SZ) respectively which has achieved good results. Additionally, at present, a number of portfolio companies are preparing to IPO.
Infinity Capital maintains close cooperation with well-known outstanding venture capital companiies and listed companies, adheres to the prudent and professional investment philosophy, and is constantly helping the investment companies to continue to grow, creating long-term and generous returns for shareholders and partners under low risk.
At the same time, Infinity Capital makes full use of its channel and resource advantages in Israel. Since 2016, it has organized four China-Israel Technology Innovation Investment Summits, which have made positive contributions to promoting innovation and pragmatic cooperation between China and Israel. In particular, the third and fourth Summit congresses jointly hosted by Huafa Group in Zhuhai, received strong support from the State, Guangdong Province and Zhuhai City, and successfully attracted more than 5000 innovative enterprises from China and Israel, and more than 10,000 guests attended the Summit. The total amount of cooperation reached exceeded 3 billion USD, which has become the largest scientific and technological innovation exchange activity between China and Israel since the establishment of diplomatic relations, and has injected new vitality into the promotion of the "Belt and Road Initiative" and cooperation in scientific and technological innovation between China and Israel.
In the future, Infinity Capital will continue to play its role as a bridge and link between China and Israel, explore high-quality innovation resources from a global perspective, and help Chinese enterprises to deeply integrate into the global scientific and technological innovation network.
中文